Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Livea vs VigorMeds

Livea
Graded #123

Higher grade

vs+18
VigorMeds
Graded #484

Lower grade

The verdict

Livea takes it — 69.7/100 to 51.7/100.

Livea grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Livea is a physician-supervised medical weight loss clinic founded in 2011 with 8 clinics in MN and WI, plus telehealth in MN, WI, Iowa, and Florida.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLivea +9
54
45
Dose & formulationLivea +24
64
40
Clinical oversightLivea +23
93
70
Labs & monitoringLivea +20
73
53
FulfillmentLivea +19
79
60
Contract termsLivea +14
55
41
Livea · left barVigorMeds · right bar

The numbers

MetricLiveaVigorMeds
WeighScore69.7/10051.7/100
GradeCC
Scorecard rank#123#484
Semaglutide$99/mo (plus a separate fee, compounded)Not disclosed
Tirzepatide$199/mo (compounded)Not disclosed
Coverage4 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Livea

Graded #123 · C

Strengths

  • LegitScript certified; physician-owned Livea Medical PLLC; Medical Director Dr. Paul Olson, internal medicine/nephrology, 40 years experience
  • Compounded sema from $99/mo and tirz from $199/mo — significantly cheaper than brand Ozempic/Wegovy ($1,000+/mo self-pay)
  • Comprehensive program: InBody scans, registered dietitian nutrition counseling, health coaching, and regular provider check-ins included
  • 15+ years established (founded 2011); 50,000+ clients served; voted Minnesota's Best Weight Loss Program 5 consecutive years
  • Medications shipped to door; same-day consultations; in-person or telehealth; typically HSA/FSA eligible

Where it loses points

  • Telehealth limited to 4 states only (MN, WI, IA, FL) — unavailable to most of the US; primarily a regional clinic network
  • Pricing ambiguous: $69/mo program fee plus separate medication cost ($99/mo sema) may bring GLP-1 total to ~$168/mo
  • Compounded tirzepatide availability uncertain — FDA announced shortage end in 2026; access subject to eligibility
  • Labs (bloodwork) not explicitly included in any published program tier; confirmed at consultation only
  • Strong MN/WI clinic focus; telehealth reach into IA and FL is newer and less established than core markets
VigorMeds

Graded #484 · C

Strengths

  • Provider-guided GLP-1 weight management via a telehealth consultation, not a pure async questionnaire
  • Care delivered by named, experienced clinicians (Dr. Anthony Kane, Dr. Kevin Kargman, Stephanie Kowatch FNP-C)
  • No-questions-asked 30-day satisfaction guarantee
  • Multi-vertical platform — also offers anti-aging/wellness, ED, and hair-loss treatment
  • Personalized treatment plan with ongoing follow-up and support

Where it loses points

  • Pricing not shown until you create an account and complete the intake
  • Specific GLP-1 medications and forms are not named on the public site
  • States served are not listed on an accessible page
  • Vigormeds LLC is a patient-management platform; prescribing is via OLA Health LLC and independent providers
  • No LegitScript certification or pharmacy-partner details published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard